Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin

INTRODUCTION: Dalbavancin is a new antibiotic against multi-drug resistant Gram (+) bacteria. Dalbavancin has an extremely long half-life. Current indication is skin and soft tissue infections (ABSSSI), but researchers have successfully administered it off-label to osteomyelitis (OM) patients. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Loupa, Chariclia V., Lykoudi, Elissavet, Meimeti, Evangelia, Moisoglou, Ioannis, Voyatzoglou, Eleftherios D., Kalantzi, Sophia, Konsta, Ekaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405994/
https://www.ncbi.nlm.nih.gov/pubmed/32801445
http://dx.doi.org/10.5455/medarh.2020.74.243-245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405994/
https://www.ncbi.nlm.nih.gov/pubmed/32801445
http://dx.doi.org/10.5455/medarh.2020.74.243-245

Ejemplares similares